R. V. J. CHARI

Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

R. V. J. CHARI, B. Martell, Janet L. Gross et al. · PubMed · 1992 · 266 citations

Medicinal Chemistry, Active Drug, Polymer-drug Conjugate +12

Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.

C. Liu, B. Mitra Tadayoni, Lizabeth A. Bourret et al. · Proceedings of the National Academy of Sciences · 1996 · 197 citations · Full text

Tumor Xenografts, Surgical Oncology, Targeted Delivery +17

Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation.

R. V. J. CHARI, K A Jackel, Lizabeth A. Bourret et al. · PubMed · 1995 · 99 citations

Immunology, Antitumor Efficacy, Immunotherapy +16

Deuterium isotope effects on the product partitioning of fluoromethylglyoxal by glyoxalase I. Proof of a proton transfer mechanism.

R. V. J. CHARI, John W. Kozarich · Journal of Biological Chemistry · 1981 · 36 citations · Full text

Partition Ratio, Proton-coupled Electron Transfer, Glycobiology +18

Postmenopausal Hyperandrogenism of Ovarian Origin

Louis H. Honor eacute, R. V. J. CHARI, H.‐D. MUELLER et al. · Gynecologic and Obstetric Investigation · 1992 · 25 citations